Cambridge, MA, United States of America

Conrad Rinaldi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Harvard College. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Conrad Rinaldi: Innovator in Aging Research

Introduction

Conrad Rinaldi is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of aging research. His work focuses on developing methods and compositions aimed at preventing or treating aging-related disorders. With a keen interest in the intersection of biology and medicine, Rinaldi's innovations are paving the way for new therapeutic approaches.

Latest Patents

Rinaldi holds a patent for "SIRT1 activating compounds." This patent outlines methods and compositions for preventing or treating aging, aging-related disorders, inflammation, and modulating immune responses in subjects. The patent emphasizes the administration of effective amounts of compounds from specific formulas, showcasing Rinaldi's commitment to advancing medical science.

Career Highlights

Conrad Rinaldi is affiliated with Harvard College, where he engages in cutting-edge research. His work at this prestigious institution allows him to collaborate with leading scientists and contribute to groundbreaking studies in the field of aging and health.

Collaborations

Rinaldi works alongside David Andrew Sinclair, a prominent figure in aging research. Their collaboration enhances the potential for innovative discoveries and advancements in understanding the biological mechanisms of aging.

Conclusion

Conrad Rinaldi's contributions to aging research through his patent and collaboration with esteemed colleagues highlight his role as an influential inventor in the scientific community. His work continues to inspire advancements in the treatment of aging-related disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…